Home [sandbox] K4D COVID-19 Resource Hub

[sandbox] K4D COVID-19 Resource Hub

Sort by: Date tagged Date published

1
2
3
…
48

1 - 25 of 1176

Women and children last? Shaking up exclusion criteria for vaccine trials

https://api.zotero.org/groups/2494380/items/6UUHGNNR?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021
On the origins of SARS-CoV-2

https://api.zotero.org/groups/2494380/items/QGUDFJCK?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021
Immune determinants of COVID-19 disease presentation and severity

https://api.zotero.org/groups/2494380/items/FMH3X549?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021
Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2: A Systematic Review and Meta-analysis

https://api.zotero.org/groups/2494380/items/YLIJMFXY?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021
RECOVERY trial closes recruitment to convalescent plasma treatment for patients hospitalised with COVID-19 — RECOVERY Trial

https://api.zotero.org/groups/2494380/items/9CXKWX4U?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19

https://api.zotero.org/groups/2494380/items/4DLT35BJ?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine

https://api.zotero.org/groups/2494380/items/65UUP86M?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021
UK funded research essential to get vaccines to the poorest in the world

https://api.zotero.org/groups/2494380/items/X7BPFY99?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021
Equitable recovery from COVID-19: bring global commitments to community level

https://api.zotero.org/groups/2494380/items/BYTSXGY3?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021
China COVID vaccine reports mixed results — what does that mean for the pandemic?

https://api.zotero.org/groups/2494380/items/BW8XGZBG?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021
2021: a new year for the WHO

https://api.zotero.org/groups/2494380/items/EPRQYBQW?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021
A New Year’s Wish: Invest in Data

https://api.zotero.org/groups/2494380/items/YT449LCJ?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021
Sedation in mechanically ventilated patients with COVID-19

https://api.zotero.org/groups/2494380/items/Q9I9J8NN?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021
Public health emergency or opportunity to profit? The two faces of the COVID-19 pandemic

https://api.zotero.org/groups/2494380/items/Z5R4HSH9?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021
G7: Make Plans to Share Excess Vaccine Now

https://api.zotero.org/groups/2494380/items/P5RSUWH8?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021
International Day of Epidemic Preparedness

https://api.zotero.org/groups/2494380/items/8QG3Y4ZN?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021
Why the evolution of vaccine resistance is less of a concern than the evolution of drug resistance

https://api.zotero.org/groups/2494380/items/X7W4WYFC?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021
ODA in Turmoil: Why Aid Definitions and Targets Will Come Under Pressure in the Pandemic Age, and What Might be Done About It?

https://api.zotero.org/groups/2494380/items/5EVHQIQV?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021
Playing Snakes and Ladders with International Development Aid: When Fragile Accounting Rules and Political Pressures Mix

https://api.zotero.org/groups/2494380/items/VUGSVGAS?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021
Genomic sequencing of SARS-CoV-2: a guide to implementation for maximum impact on public health

https://api.zotero.org/groups/2494380/items/GNVGHPW4?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021
Evidence to Impact in Crisis: How Have We Measured Up During the COVID-19 Pandemic?

https://api.zotero.org/groups/2494380/items/DTW9MJDM?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study

https://api.zotero.org/groups/2494380/items/SX3773K7?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021
Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data

https://api.zotero.org/groups/2494380/items/HWHAMQXI?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021
First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020

https://api.zotero.org/groups/2494380/items/NZYWWZ8W?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021
Estimates of severity and transmissibility of novel SARS-CoV-2 variant 501Y.V2 in South Africa

https://api.zotero.org/groups/2494380/items/3UQ3QPU6?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021

1
2
3
…
48

1 - 25 of 1176